Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson crawled time : 07:00 save search
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO
Published: 2024-04-15 (Crawled : 07:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
therapeutics
Faron’s Financial Statement Release January 1 to December 31, 2023
Published: 2024-03-13 (Crawled : 07:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
financial
PhRMA, BIO Push Back Against Rare String of Setbacks
Published: 2024-01-24 (Crawled : 07:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
rare back
Companies Bend Patent System to Head Off Competition Long-Term: Analysis
Published: 2024-01-10 (Crawled : 07:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
patent companies system
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets
Published: 2023-12-26 (Crawled : 07:00) - globenewswire.com
NBTX | $5.34 -0.74% -0.75% 28K
|
Manufacturing
|
| O: 1.37%
H: 2.54%
C: -0.15%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
commercialization china
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets
Published: 2023-12-26 (Crawled : 07:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 9.79%
H: 3.91%
C: -0.65%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
agreement china
Market for CAR-Ts Still Bright Despite FDA Cancer Safety Review
Published: 2023-12-20 (Crawled : 07:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: 0.0%
fda review cancer market
Body Lotion Market to Reach $85.3 billion, Globally, by 2032 at 4.3% CAGR: Allied Market Research
Published: 2023-12-05 (Crawled : 07:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: -1.09%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
COTY | $11.04 3.86% 0.0% 5.9M
|
Consumer Non-Durables
|
| O: -1.1%
H: 0.77%
C: -1.79%
reach research market
Virtualware Appoints John A. Cunningham, COO of VRARA and Former Unity Executive, to International Advisory Board for U.S. Expansion Drive
Published: 2023-11-27 (Crawled : 07:00) - globenewswire.com
ALSMY | $1.51 -1.78% 650K
|
Manufacturing
|
| O: -0.38%
H: 0.77%
C: 0.38%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.64%
H: 0.02%
C: -0.66%
international expansion
NANOBIOTIX Announces the Availability of a Prospectus in Connection with Capital Increases Raising Total Gross Proceeds of Approximately $50M and the Exercise by the Underwriters of the Over-Allotment Option for an Additional Amount of Approximately $3.6M
Published: 2023-11-06 (Crawled : 07:00) - globenewswire.com
NBTX | $5.34 -0.74% -0.75% 28K
|
Manufacturing
|
| O: 0.42%
H: 0.08%
C: -2.18%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
total
Astraveus awarded €10.4 million grant by the French government as part of France 2030 investment plan
Published: 2023-10-24 (Crawled : 07:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.2%
H: 0.0%
C: 0.0%
grant
Mestag Therapeutics announces the appointment of expert advisors Dr. Cassandra Choe-Juliak, Dr. Greg Elson and Samantha Vieira MBA
Published: 2023-10-12 (Crawled : 07:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
therapeutics
AstronauTx closes £48 million ($61 million) Series A financing to create new treatments for Alzheimer's disease
Published: 2023-10-09 (Crawled : 07:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
disease series alzheimer's
Vaccines Market Size To Reach USD 153.49 Billion, With at a 14.1% CAGR between 2022 to 2028 | Brandessence Market Research
Published: 2023-09-26 (Crawled : 07:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.39%
H: 0.23%
C: 0.23%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -4.29%
H: 5.93%
C: 2.89%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
DVAX | $11.35 -0.7% -0.7% 2.2M
|
Health Technology
|
| O: 0.35%
H: 2.48%
C: 0.71%
reach research market
Virtualware (MLVIR) launches VIROO 2.4, the new version of its Virtual Reality as a service (VRaaS) platform
Published: 2023-07-28 (Crawled : 07:00) - globenewswire.com
ALSMY | $1.51 -1.78% 650K
|
Manufacturing
|
| O: -0.85%
H: 1.94%
C: 0.47%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.18%
H: 0.78%
C: 0.28%
service viroo platform
Medicxi Announces $400m Medicxi IV
Published: 2023-07-27 (Crawled : 07:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.31%
H: 1.23%
C: 0.88%
Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company
Published: 2023-07-20 (Crawled : 07:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 2.02%
H: 4.45%
C: 3.98%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.2%
H: 0.7%
C: 0.27%
japan business pharmaceuticals
Janssen Announces Positive Topline Results for JNJ-2113--a Novel, First and Only Oral IL-23 Receptor Antagonist Peptide in Development for Moderate-to-Severe Plaque Psoriasis
Published: 2023-07-04 (Crawled : 07:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
PTGX | $25.23 -1.33% -1.35% 390K
|
Health Technology
| Email alert
Add to watchlist
jnj-2113 psoriasis positive il-23 topline results
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
Published: 2023-06-12 (Crawled : 07:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: -0.98%
H: 1.96%
C: -8.62%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.01%
H: 0.16%
C: -0.06%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: -1.5%
H: 1.71%
C: 0.57%
avt04 stelara biosimilar license teva
FzioMed Announces Addition of Industry Veteran to its Board of Directors
Published: 2023-05-18 (Crawled : 07:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.21%
H: 0.17%
C: -0.11%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.